Italian gene therapy startup nabs $52M for rare genetic disease that Moderna is working on
Genespire patched together a €46.6 million (about $52 million) funding round to get its lead gene therapy into the clinic in a few years. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
